Nuvation Bio Hits Day High with 10.48% Surge, Showcases Strong Intraday Performance

Nuvation Bio, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, with its stock rising by 10.48% on October 24, 2025. The stock reached an intraday high of USD 4.87, reflecting a notable performance compared to the S&P 500, which gained only 0.79% on the same day.
Over the past week, Nuvation Bio has shown a remarkable increase of 42.23%, and its one-month performance stands at an impressive 49.69%. Year-to-date, the stock has surged by 82.33%, significantly outpacing the S&P 500's 15.47% gain. However, it's important to note that the company has faced challenges, reporting negative results for the last four consecutive quarters.

Despite these hurdles, Nuvation Bio's one-year performance has been striking, with a return of 110.87%, while the S&P 500 has only achieved a 16.9% increase. The company's market capitalization is currently at USD 1,198 million, and it continues to navigate a complex financial landscape marked by negative EBITDA and declining profits.